• Home
  • About Us
    • Who We Are
    • PRIM&R Partners
    • Resources
    • Ampersand Blog
    • Career Center
  • Conference
    • Past Conferences
    • Ampersand 2024 Proceedings
    • Exhibit 2026
  • Certification
    • Eligibility
    • CIP Resources
    • CPIA Resources
    • Certification Exams
    • CIP and CPIA Councils
    • CIP and CPIA Recertification
  • Programs
    • Education at PRIM&R
    • AI Education Bundle
    • Flash Learn
    • Workshops
    • Seminars
    • Symposium
    • Panel
    • Courses
    • Webinars
    • Certificates
  • Membership
    • Member Benefits
    • Member Hub
  • Understanding Research
    • Research Ethics Timeline
    • Lead the Way
    • Research Ethics Reimagined Podcast
    • People and Perspectives
  • Public Policy
    • Research Ethics in Public Policy
    • Advocacy Toolkit
    • Resources
    • Federal Public Policy Briefings
    • Policy Comments
  • Support Us
    • Donate
    • Volunteer
    • Sponsor
    • Bookstore
  • Policies
    • PRIM&R Policy
    • Events Code of Conduct
    • Reporting Misconduct
  • Blog
login

SACHRP Recommendations

July 3, 2014 SACHRP Letter to the HHS Secretary

July 3, 2014
The Honorable Sylvia M. Burwell
Secretary of Health and Human Services
200 Independence Avenue, S.W.
Washington, D.C. 20201

Recommendation Letter

Dear Ms. Burwell:
On behalf of the Secretary’s Advisory Committee on Human Research Protections (SACHRP), I respectfully submit for your consideration comments relevant to the Department of Health and Human Services (HHS) human subjects protection regulations at 45 CFR part 46. These comments were passed by SACHRP at their March 2014 meeting.
Recommendations from the Subpart A Subcommittee
On October 5, 2014, SACHRP approved a recommendation establishing a Subpart A Subcommittee (SAS). SACHRP’s charge to this subcommittee was to review and assess all provisions of subpart A of 45 CFR part 46 (HHS’ codification of the Federal Policy for the Protection of Human Subjects, also known as the Common Rule) and relevant Office for Human Research Protections (OHRP) guidance documents, and based on this review and ongoing assessment, to develop recommendations for consideration by SACHRP in three categories: (1) recommendations on interpretation of subpart A provisions; (2) recommendations for development of new, or modification of existing, OHRP guidance; and (3) recommendations for possible revision of subpart A.
The goals of this review and assessment of subpart A of 45 CFR part 46 are threefold: (1) to enhance the protection of human subjects; (2) to reduce, where possible, regulatory burdens that do not contribute to the protection of subjects in a meaningful way; and (3) to promote scientifically and ethically valid research. To that end, SACHRP approved the attached recommendations on Assurances and Engagement from this subcommittee on March 12, 2014: Recommendations on Assurances and Engagement (Attachment A)
Recommendations from the Subcommittee on Harmonization
On October 28, 2009, SACHRP approved a recommendation establishing a Subcommittee on Harmonization (SOH). SACHRP’s charge to this subcommittee was to identify and prioritize areas in which regulations and/or guidelines for human subjects research adopted by various agencies or offices within HHS would benefit from harmonization, consistency, clarity, simplification and/or coordination. The Subcommittee will develop recommendations for consideration and possible adoption by SACHRP, to harmonize and simplify these guidelines and regulations. The goal of this subcommittee effort is to reduce unnecessary burdens on research efforts, thus resulting in better allocation of research resources and promoting the safety and welfare of human subjects.
On March 12 and 13, 2014, SACHRP passed the attached comments regarding the use of Certificates of Confidentiality and informed consent issues in clustered randomized trials:
Recommendations on Certificates of Confidentiality (Attachment B)Recommendations on Regulatory Issues in Cluster Studies (Attachment C)
On behalf of SACHRP, I would like to thank you for your consideration of this report. The committee, the Subpart A Subcommittee and the Subcommittee on Harmonization have been actively working in pursuit of their charges, and we look forward to continuing this work to enhance human subjects protections for the benefit of all Americans.
Sincerely, /s/
Jeffrey R. Botkin, M.D.Chair, Secretary’s Advisory Committeeon Human Research Protections(SACHRP)
cc: Jerry Menikoff, M.D., J.D., Executive Secretary, SACHRPJulia Gorey, J.D., Executive Director, SACHRP
Meeting Members:
Jeffrey R. Botkin, M.D., M.P.H.University of UtahSalt Lake City, Utah
James Anderson, Ph.D.University of NebraskaMedical Center
Albert J. Allen, M.D., PhD.Eli Lilly & Co.Indianapolis, Indiana
Gary Chadwick, PharmD., MPH,University of RochesterRochester, New York
Thomas Eissenberg, Ph.D.Virginia Commonwealth UniversityRichmond, Virginia
Owen Garrick, M.D., M.B.A.Bridge Clinical Research
Oakland, California
Susan Krivacic, M.P. Aff.PBG Consulting LLCAustin, Texas
Pilar Ossorio, J.D.University of Wisconsin Law SchoolMadison, Wisconsin
Suzanne M. Rivera, Ph.D., M.S.W.Case Western Reserve UniversityCleveland, Ohio
Stephen Rosenfeld, M.D., M.B.A.Quorum Review IRB
Jerry Menikoff, M.D., J.D.Executive Secretary
Julia Gorey, J.D.Executive Director
Related Recommendations
Attachment A: Recommendations on Assurances and EngagementAttachment B: Recommendations on Certificates of ConfidentialityAttachment C: Recommendations on Regulatory Issues in Cluster Studies
Content created by Office for Human Research Protections (OHRP)Content last reviewed July 3, 2014

We use cookies to enable essential functionality on our website, and analyze website traffic. By clicking Accept you consent to our use of cookies. Read about how we use cookies.

Your Cookie Settings

We use cookies to enable essential functionality on our website, and analyze website traffic. Read about how we use cookies.

Cookie Categories
Essential

These cookies are strictly necessary to provide you with services available through our websites. You cannot refuse these cookies without impacting how our websites function. You can block or delete them by changing your browser settings, as described under the heading "Managing cookies" in the Privacy and Cookies Policy.

Analytics

These cookies collect information that is used in aggregate form to help us understand how our websites are being used or how effective our marketing campaigns are.